[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: BioMed Central/SPARC Press release
- To: liblicense-l@lists.yale.edu
- Subject: RE: BioMed Central/SPARC Press release
- From: Phil Davis <pmd8@cornell.edu>
- Date: Fri, 17 May 2002 20:21:40 EDT
- Reply-To: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
We must remember that everything that this company has a long history of starting new ventures, only to sell them off to Elsevier, and we should assume that this product will go the same way. The agreement with SPARC stipulates that the journal content must remain openly accessible, but does not make any commitments to the institutional subscription model, or a commitment to affordable subscription prices in the future. --Phil Davis "In return [for SPARC's endorsement], BioMed Central has confirmed that its commitment to open access precludes it from selling its assets to any publisher that does not share its promise to keep all BioMed Central journals available through open access both retrospectively and prospectively". Philip Davis, Life Sciences Bibliographer Mann Library, Cornell University, Ithaca, NY 14853 (607) 255-7192 ; (607) 255-0318 fax pmd8@cornell.edu http://people.cornell.edu/pages/pmd8/ >-----Original Message----- >From: owner-liblicense-l@lists.yale.edu >[mailto:owner-liblicense-l@lists.yale.edu]On Behalf Of Audrey Bondar >Sent: Thursday, May 16, 2002 9:06 PM >To: liblicense-l@lists.yale.edu >Subject: Re: BioMed Central/SPARC Press release > > >Isn't it true that BioMed Central is actually owned by Elsevier? I'm sure >I read that somewhere. > >Audrey Bondar >Senior Information Resource Specialist >Henry Ford Hospital >Sladen Library >2799 West Grand Blvd. >Detroit, MI 48202
- Prev by Date: Re: BioMed Central/SPARC Press release
- Next by Date: "Fair Use" Is Getting Unfair Treatment
- Prev by thread: Re: BioMed Central/SPARC Press release
- Next by thread: RE: BioMed Central/SPARC Press release
- Index(es):